AD mice that overexpress human APP mutations accumulate soluble Aβ peptides according to a time course that depends on different factors, among which the most relevant is the coexpression of PS1 or PS2 FAD-linked mutations that accelerate the process. This evidence concerns the gene APP and Alzheimer disease.